Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

3.8K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.8K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.6K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.6K
Structure of Cadherins01:25

Structure of Cadherins

4.1K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
4.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.2K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K
Rab Proteins01:14

Rab Proteins

4.6K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.6K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

4.3K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications.

International journal of laboratory hematology·2026
Same author

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Human pathology·2026
Same author

Molecular Pathology of Mature Lymphoid Neoplasms.

Surgical pathology clinics·2026
Same author

Breast-implant associated unicentric castleman disease: a case report.

Current problems in cancer. Case reports·2026
Same author

Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Blood·2026
Same author

Isolated <i>KRAS</i> and <i>NRAS</i> mutations in adults with monocytosis and/or cytopenia(s).

Haematologica·2025

Related Experiment Video

Updated: Nov 17, 2025

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography
10:50

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography

Published on: March 9, 2010

17.6K

Ionized Calcium Binding Adaptor Molecule 1 (IBA1).

Xiaoming Zhang1, Li-Ping Wang1, Amy Ziober1

  • 1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia.

American Journal of Clinical Pathology
|February 14, 2021
PubMed
Summary

Ionized calcium binding adaptor molecule 1 (IBA1) is a highly sensitive and specific marker for diagnosing monocytic, histiocytic, and dendritic cell neoplasms. This study found IBA1 superior to CD14, CD68, and CD163 in hematopathology.

Keywords:
Acute leukemiaFlow cytometryHistiocytic and dendritic cell neoplasmsImmunohistochemistryIonized calcium binding adaptor molecule 1 (IBA1)Monocytic differentiationNonspecific esterase cytochemistry

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.9K
Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.3K

Related Experiment Videos

Last Updated: Nov 17, 2025

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography
10:50

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography

Published on: March 9, 2010

17.6K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.9K
Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.3K

Area of Science:

  • Hematopathology
  • Immunohistochemistry
  • Oncology

Background:

  • Ionized calcium binding adaptor molecule 1 (IBA1) is a known marker for microglia/macrophages.
  • Its utility in human hematologic malignancies, specifically monocytic, histiocytic, and dendritic cell neoplasms, remained unexplored.
  • This study aimed to fill that knowledge gap.

Purpose of the Study:

  • To evaluate the expression of IBA1 in various mature and immature neoplasms of monocytic, histiocytic, and dendritic cell origin.
  • To compare the diagnostic performance of IBA1 with established markers like CD14, CD68, and CD163 in these contexts.

Main Methods:

  • Immunohistochemistry was employed to detect IBA1, CD14, CD68, and CD163 expression.
  • A total of 114 cases were analyzed, including tissue-based and bone marrow-based neoplasms of monocytic/histiocytic/dendritic cell lineage, along with control groups.

Main Results:

  • IBA1 was expressed in all tested mature tissue-based histiocytic/dendritic cell neoplasms (20/20).
  • In bone marrow cases, IBA1 showed high positivity in acute myeloid leukemias with monocytic differentiation (48/53), blastic plasmacytoid dendritic cell neoplasms (2/2), and chronic myelomonocytic leukemias (4/4).
  • IBA1 demonstrated superior sensitivity (93.7%) and specificity (97.1%) compared to CD14, CD68, and CD163.

Conclusions:

  • IBA1 is identified as a novel diagnostic marker for neoplasms of monocytic, histiocytic, and dendritic cell origin.
  • Its high sensitivity and specificity make it a valuable tool in hematopathology.
  • IBA1 offers improved diagnostic accuracy over existing markers for these specific malignancies.